Compounds > nafamostat

nafamostat and citric acid, anhydrous

nafamostat has been researched along with citric acid, anhydrous in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Matsuda, O1
Kano, M; Shimoyama, T; Shintani, S; Wada, M; Yamashita, M1
Fujimoto, S; Fujita, H; Hazama, Y; Kuhara, K; Moriyama, A; Nishimura, S; Ohtake, C; Sakuma, R1
Goldstein, SL; Ide, K; Krallman, KA; Lazear, D; Maeno, M; Miyaji, MJ; Takashima, K1
Asano, K; Endo, A; Fujii, T; Ikeda, J; Kageyama, A; Kameda, S; Miyayama, N; Takagi, T; Uezono, S1

Other Studies

5 other study(ies) available for nafamostat and citric acid, anhydrous

ArticleYear
[Anticoagulation].
    Nihon rinsho. Japanese journal of clinical medicine, 1991, Volume: 49 Suppl

    Topics: Benzamidines; Blood Coagulation; Citrates; Citric Acid; Gabexate; Guanidines; Heparin; Humans; Molecular Weight; Renal Dialysis

1991
[Anticoagulant in plasmapheresis].
    Nihon rinsho. Japanese journal of clinical medicine, 1991, Volume: 49 Suppl

    Topics: Anticoagulants; Benzamidines; Biocompatible Materials; Citrates; Citric Acid; Gabexate; Guanidines; Heparin; Humans; Membranes, Artificial; Plasmapheresis

1991
Nafamostat mesilate, a noncalcium compound, as an anticoagulant, induces calcium-dependent haemolysis when infused with packed erythrocytes.
    Transfusion medicine (Oxford, England), 2012, Volume: 22, Issue:3

    Topics: Anticoagulants; Benzamidines; Calcium; Citrates; Citric Acid; Drug Evaluation, Preclinical; Edetic Acid; Erythrocyte Membrane; Erythrocytes; Flow Cytometry; Gabexate; Glucose; Guanidines; Hemoglobins; Hemolysis; Humans; In Vitro Techniques; Infusion Pumps; Infusions, Intravenous; L-Lactate Dehydrogenase; Membrane Lipids; Phosphatidylserines; Solutions

2012
Comparison of nafamostat mesilate to citrate anticoagulation in pediatric continuous kidney replacement therapy.
    Pediatric nephrology (Berlin, Germany), 2022, Volume: 37, Issue:11

    Topics: Acute Kidney Injury; Anticoagulants; Benzamidines; Child; Citrates; Citric Acid; Continuous Renal Replacement Therapy; Electrolytes; Guanidines; Hemorrhage; Humans; Retrospective Studies; Serine Proteases

2022
Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study.
    BMC nephrology, 2023, 01-16, Volume: 24, Issue:1

    Topics: Acute Kidney Injury; Adult; Anticoagulants; Blood Coagulation; Citric Acid; Continuous Renal Replacement Therapy; Heparin; Humans; Renal Replacement Therapy

2023